Determinants of Eating Disorder Risk in Pre-intervention Bariatric Surgery Candidates.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obesity, Mild
- Sponsor
- Kuwait University
- Enrollment
- 376
- Locations
- 1
- Primary Endpoint
- Eating Disorder Screening
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The aim of the observational cross-sectional study is to determine the prevalence and correlates of disordered eating among candidates for bariatric surgery in the BariPredict cohort.
The study aims to answer the following question on whether the prevalence of disordered eating is higher in individuals that are candidates of bariatric surgery compared to the general population with obesity.
Detailed Description
Participants referred to Jaber Al Ahmad Al Sabah Hospital, Hawalli, Kuwait, for bariatric surgery were consecutively screened for the study. A cross-sectional analysis was performed on a subgroup of this cohort with complete baseline data. The analysis investigates the influence of psychological factors associated with obesity before bariatric surgery.
Investigators
Dana AlTarrah
Assistant Professor
Kuwait University
Eligibility Criteria
Inclusion Criteria
- •Obesity BMI \> 30 kg/m2
- •18 years and older
Exclusion Criteria
- •BMI \< 30 kg/m2
Outcomes
Primary Outcomes
Eating Disorder Screening
Time Frame: 1 Day
A validated SCOFF questionnaire will be self-administered to patients attending their first preoperative bariatric surgery appointment. The SCOFF questionnaire is a simple 5-question test developed to assess the possible presence of an eating disorder. The S in SCOFF stands for "sick" (to vomit). The O stands for "one stone" of weight (i.e., 6.35 kg). The letters C, F and F stand for "control", "fat" and "food" respectively. Although the SCOFF is not used for diagnostic purposes, a score of 2 or more positive answers raises the index of suspicion of eating disorders, highlighting the need for a more detailed psychological history .The SCOFF has been previously validated in Arab populations.
Secondary Outcomes
- Depression(1 Day)
- Anxiety(1 Day)
- Obesity(1 Day)